Near-Monopolies On HCV Diagnostics Curb Competition, Keep Prices High, Research Finds 24/10/2018 by David Branigan, Intellectual Property Watch 1 Comment Monopoly prices of diagnostic tools and lack of competition in the market constitute a barrier to treatment for people with hepatitis C virus (HCV), but the increased use of “open” diagnostic platforms could reduce prices, a health advocacy research study has found.
US Interference In EU SPC Manufacturing Waiver “Unacceptable,” Says EU Generic Industry Group 24/10/2018 by Intellectual Property Watch Leave a Comment Generics industry group Medicines for Europe has declared United States interference in the European Union legislative process on the supplementary protection certificate (SPC) manufacturing waiver “unacceptable,” and an attempt to “influence the outcome of this EU legislative proposal.”
WHO Members Consider Possible Changes To Pandemic Influenza Framework 23/10/2018 by Catherine Saez, Intellectual Property Watch 1 Comment A hundred years ago, the influenza pandemic known as the “Spanish flu” infected one-third of the world population, and resulted in an estimated 50 million deaths. Last week, the World Health Organization held a consultation on possible changes to its 2011 agreement to prepare for the next pandemic influenza. Two major questions were on the table: whether to extend its agreement to seasonal influenza, and how to deal with pandemic influenza genetic information, which is increasingly used instead of biological samples of viruses.
ICANN63: The “Practical Peace Project” – Tested By IP Rights Concerns And A Privacy Tussle 23/10/2018 by Monika Ermert for Intellectual Property Watch Leave a Comment BARCELONA, Spain — The Internet Corporation for Assigned Names and Numbers (ICANN) is struggling over Europe’s privacy legislation. Is there a data “war” in the making? It is exactly 20 years since the founding of ICANN and two years after being finally fully privatized, and the self-regulatory internet domain name body has been named a “practical peace project underway” by its President and CEO Göran Marby. But it is now struggling with an old issue: privacy and access to personal information in the Whois database.
G77+China Plan To Take UN TB Declaration Forward: Increased Resources, Access To Medicines 19/10/2018 by David Branigan, Intellectual Property Watch 2 Comments The Group of 77 developing countries plus China delivered a statement at the recent United Nations High-Level Meeting on Tuberculosis, calling for forward progress on the commitments to funding and action made in the UN political declaration on TB.
New US Law Requires Reporting Of Biologic, Biosimilar “Pay-for-Delay” Pacts 18/10/2018 by Dugie Standeford for Intellectual Property Watch Leave a Comment The Patient Right to Know Drug Prices Act became effective in the United States on 10 October. Among other things, it extends to biologic and biosimilar products a 2003 law requiring drug manufacturers to notify US antitrust authorities of patent settlement agreements. The idea is to cut down on so-called “pay-for delay” tactics which can slow the introduction of cheaper medicines into the market.
Research Group Identifies Over-Patenting Of Pharmaceuticals In India, Calls For Patent Reform 17/10/2018 by David Branigan, Intellectual Property Watch 2 Comments The tricontinental research group “accessibsa” has found that while the Indian Patent Office rejects 40 percent of pharmaceutical patent applications, it should be rejecting 90 percent of applications to comply with Indian patent law, according to the results of its recent study of Indian patent data.
WEF: US Most Competitive, But Idea Generation, Agility Will Shape Future Growth 17/10/2018 by John Zarocostas for Intellectual Property Watch Leave a Comment The generation of ideas, entrepreneurial culture, openness, and agility – by companies, policymakers, and workers – to adapt quickly and embrace change and not resist it, are factors that will have the greatest impact in driving growth and competitiveness in the years ahead in a world increasingly transformed by new, digital technologies, a report by the World Economic Forum said.
Antimicrobial Resistance At The World Investment Forum: UNCTAD, WHO Join Forces 16/10/2018 by Catherine Saez, Intellectual Property Watch Leave a Comment The World Investment Forum 2018, a biennial event organised by the United Nations Conference on Trade and Development (UNCTAD), will hold a session on health this year jointly with the World Health Organization. The session will address the need for investment in the development of new antibiotics, hoping to raise interest among investors.
World Health Summit Berlin: New Global Action Plan; Gates And Merkel To Open Global Challenges 15/10/2018 by Monika Ermert for Intellectual Property Watch Leave a Comment BERLIN — Ten years after establishing the Berlin World Health Summit, the M8 alliance of medical institutes around the globe sees some noticeable progress in political commitment to the health agenda. “Gifts” presented at the opening ceremony yesterday in the German capital include the announcement of German Health Minister Jens Spahn to establish a Hub for Global Health and step up its financial contributions to the World Health Organization (WHO) to 115 million euros over the next four years. The three-day summit also will receive a global action plan to catch up with the United Nations Sustainable Development Goal (SDG) 3 on health and well-being for all.